Proteome Sciences (LON:PRM) Posts Earnings Results

Proteome Sciences (LON:PRM) issued its quarterly earnings results on Wednesday. The company reported GBX (0.41) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 23.85% and a negative net margin of 61.46%.

Proteome Sciences Stock Performance

PRM traded up GBX 0.18 during trading on Friday, reaching GBX 1.58. The company’s stock had a trading volume of 4,574,178 shares, compared to its average volume of 400,438. Proteome Sciences has a 52-week low of GBX 1.11 and a 52-week high of GBX 4.40. The company’s fifty day moving average price is GBX 1.70 and its 200-day moving average price is GBX 1.63. The company has a market capitalization of £5.54 million, a price-to-earnings ratio of -1.52 and a beta of 0.16. The company has a debt-to-equity ratio of -161.07, a quick ratio of 0.37 and a current ratio of 0.12.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.